Comparison of efficacy and safety of pazopanib and sunitinib in patients with metastatic renal cell carcinoma patients with poor-risk features
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 14 Jul 2017 New trial record